Pinz Capital Management, LP Atara Biotherapeutics, Inc. Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$14.0 - $20.72 $1.55 Million - $2.29 Million
-110,500 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$12.67 - $26.23 $1.4 Million - $2.9 Million
110,500 New
110,500 $2.17 Million
Q3 2020

Nov 16, 2020
SELL
$11.92 - $15.87 $1.92 Million - $2.56 Million
-161,100 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$7.53 - $14.93 $1.21 Million - $2.41 Million
161,100 New
161,100 $2.35 Million

Others Institutions Holding ATRA

# of Institutions
87
Shares Held
85M
Call Options Held
18.4K
Put Options Held
51.3K
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $710M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email